TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis. (Q41598833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author

Harikrishna Nakshatri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1

Susan M Perkins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

5

Kathy D Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

6

George Sandusky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Casey Bales

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Tudor Vladislav

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Sandra Althouse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Sunil Badve

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

English

0 references

publication date

10 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

519-531

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26160249%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-015-3492-2

19 February 2020

exact match

0 references

cites work

Biological determinants of endocrine resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Identification of estrogen-responsive genes involved in breast cancer metastases to the bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

21 January 2018

FOXA1 in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

FOXA1 is a key determinant of estrogen receptor function and endocrine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Wwox and Ap2gamma expression levels predict tamoxifen response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

PROGgeneV2: enhancements on the existing database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

FOXA1 is an independent prognostic marker for ER-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Sumoylation pathway is required to maintain the basal breast cancer subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Delineation of a FOXA1/ERα/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Genome-wide functional synergy between amplified and mutated genes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2

Dual role of AP-2? in ErbB-2-induced mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3492-2